U.S. flag

An official website of the United States government

NM_014251.3(SLC25A13):c.1638_1660dup (p.Ala554fs) AND Citrullinemia type II

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Feb 24, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000006371.9

Allele description [Variation Report for NM_014251.3(SLC25A13):c.1638_1660dup (p.Ala554fs)]

NM_014251.3(SLC25A13):c.1638_1660dup (p.Ala554fs)

Gene:
SLC25A13:solute carrier family 25 member 13 [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
7q21.3
Genomic location:
Preferred name:
NM_014251.3(SLC25A13):c.1638_1660dup (p.Ala554fs)
Other names:
1638ins23; p.Ala554Glyfs*17
HGVS:
  • NC_000007.13:g.95751240_95751241insCCCGGGCAGCCACCTGTAATCTC
  • NC_000007.14:g.96121929_96121951dup
  • NG_012247.2:g.205197_205219dup
  • NM_001160210.2:c.1641_1663dup
  • NM_014251.3:c.1638_1660dupMANE SELECT
  • NP_001153682.1:p.Ala555fs
  • NP_055066.1:p.Ala554fs
  • NC_000007.13:g.95751240_95751241insCCCGGGCAGCCACCTGTAATCTC
  • NC_000007.13:g.95751241_95751263dup
  • NC_000007.13:g.95751241_95751263dupCCCGGGCAGCCACCTGTAATCTC
  • NM_014251.2:c.1638_1660dup23
  • NM_014251.3:c.1638_1660dup
  • NR_027662.2:n.1664_1686dup
Protein change:
A554fs
Links:
OMIM: 603859.0003; dbSNP: rs80338725
NCBI 1000 Genomes Browser:
rs80338725
Molecular consequence:
  • NM_001160210.2:c.1641_1663dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_014251.3:c.1638_1660dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NR_027662.2:n.1664_1686dup - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Citrullinemia type II
Identifiers:
MONDO: MONDO:0016603; MedGen: C1863844

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000026553OMIM
no assertion criteria provided
Pathogenic
(Jun 1, 1999)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

SCV003845174Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Pathogenic
(Feb 24, 2023)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

The gene mutated in adult-onset type II citrullinaemia encodes a putative mitochondrial carrier protein.

Kobayashi K, Sinasac DS, Iijima M, Boright AP, Begum L, Lee JR, Yasuda T, Ikeda S, Hirano R, Terazono H, Crackower MA, Kondo I, Tsui LC, Scherer SW, Saheki T.

Nat Genet. 1999 Jun;22(2):159-63.

PubMed [citation]
PMID:
10369257

Molecular findings in children with inherited intrahepatic cholestasis.

Wang NL, Lu Y, Gong JY, Xie XB, Lin J, Abuduxikuer K, Zhang MH, Wang JS.

Pediatr Res. 2020 Jan;87(1):112-117. doi: 10.1038/s41390-019-0548-8. Epub 2019 Aug 26.

PubMed [citation]
PMID:
31450232
See all PubMed Citations (3)

Details of each submission

From OMIM, SCV000026553.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

In a patient with adult-onset citrin deficiency (CDAA; 603471), Kobayashi et al. (1999) identified a 23-bp homozygous insertion (c.1638ins23) in exon 16 of the SLC25A13 gene, resulting in a frameshift at codon 554 and the addition of 16 new amino acids. A stop codon was introduced at position 570, leading to premature termination of the C terminus of citrin. The inserted sequence was apparently a tandem repeat of 23 bp from nucleotide 1638-1660 of SLC25A13 cDNA.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV003845174.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

Variant summary: SLC25A13 c.1638_1660dup23 (p.Ala554GlyfsX17) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic within ClinVar (e.g. c.1799dup [p.Tyr600Ter], c.1813C>T [p.Arg605Ter]). The variant allele was found at a frequency of 8.8e-05 in 251412 control chromosomes (gnomAD), predominantly at a frequency of 0.0012 within the East Asian subpopulation in the gnomAD database. This frequency is not significantly higher than estimated for a pathogenic variant in SLC25A13 causing Citrullinemia Type II (8.8e-05 vs 0.0012), allowing no conclusion about variant significance. c.1638_1660dup23 has been reported in the literature as a biallelic genotype in multiple individuals affected with Citrullinemia (e.g. Song_2011, Wang_2020). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Four ClinVar submitters have assessed the variant since 2014: all four classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 16, 2025